Hypercalcemia and childhood cancer: A 7-year experience

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 1, 2005, Pages 23-27

  Kerdudo, Cecile ^a   Aerts, Isabelle ^a   Fattet, Sarah ^a   Chevret, Laurent ^b   Pacquement, Helene ^a   Doz, Francois ^a   Michon, Jean ^a   Garabedian, Monique ^c   Orbach, Daniel ^a  

^a INSTITUT CURIE   (France)

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Cancer; Children; Hypercalcemia; Pamidronate

Indexed keywords

CALCITONIN; CARBOPLATIN; CORTICOSTEROID; FUROSEMIDE; GLUCOCORTICOID; LOOP DIURETIC AGENT; PAMIDRONIC ACID; PHOSPHORUS; RETINOIC ACID; VITAMIN D;

ADOLESCENT; ALLERGIC REACTION; ARTICLE; BRAIN EDEMA; CALCIUM BLOOD LEVEL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DIURESIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EWING SARCOMA; FATALITY; FEMALE; GRANULOSA CELL TUMOR; HEMATOLOGIC MALIGNANCY; HUMAN; HYDRATION; HYPERCALCEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; INFANT; KIDNEY CALCIFICATION; KIDNEY FAILURE; MALE; MALNUTRITION; NEUROBLASTOMA; NEWBORN; OSTEOSARCOMA; PLASMACYTOMA; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RHABDOID TUMOR; RHABDOMYOSARCOMA; RISK FACTOR; UTERUS CARCINOMA; VOMITING;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DIPHOSPHONATES; FEMALE; HUMANS; HYPERCALCEMIA; INFANT; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 12944291393     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000151932.47598.00     Document Type: Article

References (33)

1. McKay C, Furman WL. Hypercalcemia complicating childhood malignancies. Cancer. 1993;72:256-260.
2. Leblanc A, Caillaud JM, Hartmann O, et al. Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. A study of 11 cases. Cancer. 1984;54:2132-2136.
3. Bilezikian JP. Management of acute hypercalcemia. N Engl J Med. 1992;326:1196-1203.
4. Kutluk MT, Hazar V, Akyuz C, et al. Childhood cancer and hypercalcemia: report of a case treated with pamidronate. J Pediatr. 1997;130:828-831.
5. Mathur M, Sykes JA, Saxena VR, et al. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin. Pediatr Crit Care Med. 2003;4:252-255.
6. Budayr AA, Nissenson RA, Klein RF, et al. Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia. Ann Intern Med. 1989;111:807-812.
7. Papadakis V, Vlachopapadopoulou EA, Levine L. Rhabdoid tumor of the kidney with humoral hypercalcemia and parathyroid hormone-related protein production. Med Pediatr Oncol. 1995;24:133-136.
8. Silverman P, Distelhorst CW. Metabolic emergencies in clinical oncology. Semin Oncol. 1989;16:504-515.
9. Mundy GR, Guise TA, Bilezikian JP. Hypercalcemia of malignancy Management of acute hypercalcemia. Am J Med. 1997;103:134-145.
10. Lamy OBP. Hypercalcemia of malignancy. Am J Cancer. 2002;1:227-292.
11. Schmid I, Stachel D, Schon C, et al. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children. Klin Padiatr. 2001;213:30-34.
12. Young G, Shende A. Use of pamidronate in the management of acute cancer-related hypercalcemia in children. Med Pediatr Oncol. 1998;30:117-121.
13. Lteif AN, Zimmerman D. Bisphosphonates for treatment of childhood hypercalcemia. Pediatrics. 1998;102:990-993.
14. Sakamoto O, Yoshinari M, Rikiishi T, et al. Hypercalcemia due to all-trans retinoic acid therapy for acute promyelocytic leukemia: a case report of effective treatment with bisphosphonate. Pediatr Int. 2001;43:688-690.
15. Kutluk T, Akyuz C, Yalcin B, et al. Use of pamidronate in the management of acute cancer-related hypercalcemia in children. Med Pediatr Oncol. 1998;31:39.
16. Boudailliez BR, Pautard BJ, Sebert JL, et al. Leukaemia-associated hypercalcaemia in a 10-year-old boy: effectiveness of aminohydroxypropylidene biphosphonate. Pediatr Nephrol. 1990;4:510-511.
17. De Schepper J, de Pont S, Smitz J, et al. Metabolic disturbances after a single dose of 30 mg pamidronate for leukaemia-associated hypercalcaemia in an 11-year-old boy. Eur J Pediatr. 1999;158:765-766.
18. Farran RP, Zaretski E, Egeler RM. Treatment of Langerhans cell histiocytosis with pamidronate. J Pediatr Hematol Oncol. 2001;23:54-56.
19. de Camargo B, Salateo R, Gutierrez y Lamelas R, et al. Unusual clinical evolution of a paratesticular alveolar rhabdomyosarcoma in a child. Med Pediatr Oncol. 1999;33:422-424.
20. Kawasaki H, Takayama J, Nagasaki K, et al. Hypercalcemia in children with rhabdomyosarcoma. J Pediatr Hematol Oncol. 1998;20:327-329.
21. Amar AM, Tomlinson G, Green DM, et al. Clinical presentation of rhabdoid tumors of the kidney. J Pediatr Hematol Oncol. 2001;23:105-108.
22. Guise TA, Mundy GR. Cancer and bone. Endocr Rev. 1998;19:18-54.
23. Villablanca JG, Khan AA, Avramis VI, et al. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid. Am J Pediatr Hematol Oncol. 1993; 15:410-415.
24. Yavuz H. Familiar drugs for the treatment of hypercalcemia. J Pediatr. 1998;133:311-312.
25. McLean TW, Pritchard J. Langerhans cell histiocytosis and hypercalcemia: clinical response to indomethacin. J Pediatr Hematol Oncol. 1996;18:318-320.
26. Benford HL, Frith JC, Auriola S, et al. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol. 1999;56:131-140.
27. Body JJ, Bartl R, Burckhardt P, et al. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. J Clin Oncol. 1998;16:3890-3899.
28. Hillner BE, Ingle JN, Berenson JR, et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol. 2000;18:1378-1391.
29. Glorieux FH, Bishop NJ, Plotkin H, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339:947-952.
30. Kone Paut I, Gennari JM, Retornaz K, et al. [Biphosphonates in children: present and future]. Arch Pediatr. 2002;9:836-842.
31. Shaw NJ, Boivin CM, Crabtree NJ. Intravenous pamidronate in juvenile osteoporosis. Arch Dis Child. 2000;83:143-145.
32. Yap AS, Hockings GI, Fleming SJ, et al. Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment. Clin Nephrol. 1990;34:225-229.
33. Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001;19:558-567.